Menu
Recruiting NCT05090943

Adult Tic Disorders Registry

— Observational Tic Disorders

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: QOL to be completed by the participant.
Who it may be relevant to
Registry conditions: Tic Disorders. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The purpose of this study is to develop the adult tic disorders registry in order to characterize the relationship between tic severity and tic-related impairment in women compared to men with tic disorders.

Interventions

  • Other QOL to be completed by the participant
    The scales (PUTS, OCI, TS-QOL, ASRS, GAD-7, PHQ9, TAPS) to be completed by the participant

Primary outcome measures

  • Correlation between Quality of Life and TICs severity [Time frame: 6 months]
Secondary outcome measures (1)
  • Change in TICs [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Age >18 years
  • Patients with Tic disorders
  • Given the non-opposition

Non Inclusion criteria

  • No affiliation to a French health social insurance
  • Significant congenital disorders that may affect understanding of assessments
  • Patients under guardianship or curatorship

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 7 centers
  • CHU Clermont-Ferrand — Clermont-Ferrand
  • CHU Limoges — Limoges
  • CHU Marseille — Marseille
  • Service de Neurologie, GH Pitié Salpêtrière — Paris
  • CHU Poitiers — Poitiers
  • CHU Nantes — Saint-Herblain
  • CHU Strasbourg — Strasbourg

Identifiers

NCT: NCT05090943 · APHP210801

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗